K2 Research Network.
Everything we know about vitamin K2, isn’t everything there is to know about to vitamin K2.
Recent studies into vitamin K2 are now starting to show us just how important it is for healthy bones, healthy hearts and more which is why we’ve established the K2 Research Network.
Dedicated to our Craft
As proud leaders in our industry, we at Balchem Human and Nutrition have a responsibility to advance what we know about vitamin K2, supporting research and engaging directly with the scientific community.
We also understand the value of truly independent research.
That means not interfering with scientists’ work, and studies that are conducted entirely independently. Their raw data and results are their raw data and results, we don’t see anything before data is ready for peer-reviewed publication.
By supporting research, we’re hoping to get even more of the scientific community involved, and discover more about vitamin K2, together.
Research Areas
We’re a bioscience company through and through, with a global network of researchers, thought-leaders and K2 experts. Together, we are uncovering the future of vitamin K2, and discovering the benefits it can offer to everyone.
- Bone Health: Strength and maintenance
- Cardiovascular Health: Calcification prevention and reduction, heart health improvement
- Immune Health: Improvement of inflammation markers and oxidative stress.
- Mobility and Sports Nutrition: Athletic performance, muscle mass, muscle recovery
- Neurology: Parkinson’s disease
We’re proud to take a leading role in research, including running 10 clinical trials.
The K2 Research Network
A direct dialogue with scientists is more important than ever. We believe the internet makes it too easy for claims about health and nutrition to go unchecked.
Credible, reliable sources can be hard to come by, so we foster close relationships with a growing network of experts, all specialists in their field, all working together to shape the future of vitamin K2.
University Hospitals
Cleveland, Ohio, United States
Dr. Grace McComsey, MD, FIDSA, Vice President of Research and Associate Chief Scientific Officer at University Hospitals (USA)
Frederiksberg Hospital
Copenhagen, Denmark
Prof. Allan Linneberg, MD, PhD, Director of Center for Clinical Research and Prevention
Odense University Hospital
Odense, Denmark
Prof. Axel Diederichsen, Odense University Hospital, Department of Cardiology
University Medical Center Schleswig-Holstein (UKSH)
Lübeck, Germany
Dr. med. Jannik Prasuhn, Department of Neurology/ Institute of Neurogenetics, Center for Brain, Behaviour and Metabolism (CBBM)
University of Glasgow
Glasgow, United Kingdom
Dr Stuart Gray, BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow
Lithuanian Sports University
Kaunas, Lithuania
Prof. Aivaras Ratkevicius Lithuanian Sports University, Kaunas, Lithuania
Dasman Diabetes Institute
Kuwait City, Kuwait
Dr. Dalal Alsaeed, Dasman Diabetes Institute, Kuwait, Clinical Operation Manager
NIZO, Ede
The Netherlands
Oslo University Hospital
Oslo, Norway
Marton König, MD, PhD, Department of Neurology, Oslo University Hospital
Taipei Medical University
Taiwan
Sao Paulo State University
Sao Paulo, Brazil
Roberta Okamoto, Associate Professor, Basic Sciences Department
